标题
Endothelial ERK signaling controls lymphatic fate specification
作者
关键词
-
出版物
JOURNAL OF CLINICAL INVESTIGATION
Volume 123, Issue 3, Pages 1202-1215
出版商
American Society for Clinical Investigation
发表日期
2013-02-09
DOI
10.1172/jci63034
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lymphatic endothelial progenitors bud from the cardinal vein and intersomitic vessels in mammalian embryos
- (2012) Y. Yang et al. BLOOD
- RASA1 maintains the lymphatic vasculature in a quiescent functional state in mice
- (2012) Philip E. Lapinski et al. JOURNAL OF CLINICAL INVESTIGATION
- YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy
- (2012) A. von Gise et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prox1 dosage controls the number of lymphatic endothelial cell progenitors and the formation of the lymphovenous valves
- (2011) R. S. Srinivasan et al. GENES & DEVELOPMENT
- Lymphatic vascular morphogenesis in development, physiology, and disease
- (2011) Stefan Schulte-Merker et al. JOURNAL OF CELL BIOLOGY
- MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1L613V mutation
- (2011) Xue Wu et al. JOURNAL OF CLINICAL INVESTIGATION
- A MEK-independent role for CRAF in mitosis and tumor progression
- (2011) Ainhoa Mielgo et al. NATURE MEDICINE
- The Transcriptional Control of Lymphatic Vascular Development
- (2011) Mathias Francois et al. PHYSIOLOGY
- Akt/Protein Kinase B Is Required for Lymphatic Network Formation, Remodeling, and Valve Development
- (2010) Fei Zhou et al. AMERICAN JOURNAL OF PATHOLOGY
- VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis
- (2010) Luqing Zhang et al. CELL RESEARCH
- Endothelial cell plasticity: how to become and remain a lymphatic endothelial cell
- (2010) G. Oliver et al. DEVELOPMENT
- Early growth response protein 1 acts as an activator of SOX18 promoter
- (2010) Isidora Petrovic et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Current views on the function of the lymphatic vasculature in health and disease
- (2010) Y. Wang et al. GENES & DEVELOPMENT
- The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells
- (2010) R. S. Srinivasan et al. GENES & DEVELOPMENT
- ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish
- (2010) Bin Ren et al. JOURNAL OF CLINICAL INVESTIGATION
- The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation
- (2009) William E Tidyman et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Sox7 and Sox17 are strain-specific modifiers of the lymphangiogenic defects caused by Sox18 dysfunction in mice
- (2009) B. Hosking et al. DEVELOPMENT
- Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85α, p55α, and p50α
- (2009) Carla Mouta-Bellum et al. DEVELOPMENTAL DYNAMICS
- Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity
- (2008) N. C. Johnson et al. GENES & DEVELOPMENT
- The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders
- (2008) Yoko Aoki et al. HUMAN MUTATION
- PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype–phenotype correlation in Korean patients with Noonan syndrome
- (2008) Jung Min Ko et al. JOURNAL OF HUMAN GENETICS
- Deletion of Vascular Endothelial Growth Factor C (VEGF-C) and VEGF-D Is Not Equivalent to VEGF Receptor 3 Deletion in Mouse Embryos
- (2008) P. Haiko et al. MOLECULAR AND CELLULAR BIOLOGY
- Sox18 induces development of the lymphatic vasculature in mice
- (2008) Mathias François et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More